Mario13/E+ via Getty Images
Arcturus wins new bullish call at Cantor on experimental COVID-19 shot
- Arcturus Therapeutics (NASDAQ:ARCT) has added ~1.3%
in the pre-market after Cantor Fitzgerald initiated its coverage with an overweight recommendation highlighting…
